Mersana Therapeutics Inc (MRSN)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 14.69M | 7.8M | 10.65M | 7.7M | 10.7M | 9.25M | 2.29M | 12.6M |
営業利益 | -45.83M | -57.8M | -56.5M | -43.94M | -21.43M | -21M | -25.46M | -12.07M |
税引前収入 | -44.92M | -56.16M | -54.31M | -41.66M | -19.54M | -19.31M | -24.27M | -11.08M |
純利益 | -44.92M | -56.16M | -54.31M | -41.66M | -19.54M | -19.31M | -24.27M | -11.5M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -45.83M | -57.8M | -56.5M | -43.94M | -21.43M | -21M | -25.46M | -12.07M |
EBITDA | -45.54M | -57.48M | -56.18M | -43.51M | -20.98M | -20.58M | -25.05M | -11.67M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 25.17M | 17.55M | 10.59M | 42.12M | 828k | 43k | 26.58M | 36.86M |
営業利益 | -13.82M | -39.62M | -65.66M | -30.2M | -88.11M | -168.86M | -203.77M | -179.67M |
税引前収入 | -13.7M | -38.71M | -64.26M | -28.21M | -88.05M | -170.06M | -204.21M | -171.67M |
純利益 | -13.7M | -38.71M | -64.26M | -28.21M | -88.05M | -170.06M | -204.21M | -171.67M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -2.352 | -1.7 | -2.766 | -0.621 | -1.279 | -2.307 | -1.961 | -1.424 |
EBIT | -13.82M | -39.62M | -65.66M | -30.2M | -88.11M | -168.86M | -203.77M | -179.67M |
EBITDA | -13.17M | -38.69M | -64.4M | -28.96M | -87.1M | -168M | -202.84M | -178.15M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約